Associations between neuropsychiatric symptoms and incident Alzheimer's dementia in men versus women.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 09 11 2022
accepted: 17 12 2022
revised: 16 12 2022
pubmed: 27 12 2022
medline: 22 3 2023
entrez: 26 12 2022
Statut: ppublish

Résumé

To examine whether associations between individual neuropsychiatric symptoms (NPS) and incident Alzheimer's dementia (AD) differ in men versus women. Data were acquired from the National Alzheimer's Coordinating Center (NACC) Uniform Data Set. Two sets of older (≥ 60 years) participants were formed: one of cognitively unimpaired (CU) individuals, and one of participants with mild cognitive impairment (MCI). NPS were assessed using the Neuropsychiatric Inventory Questionnaire. Cox proportional hazards models examined associations between individual NPS and AD incidence separately for each participant set. These models featured individual NPS, sex, NPS by sex interactions as well as a number of covariates. The analysis involved 9,854 CU individuals followed for 5.5 ± 3.8 years and 6,369 participants with MCI followed for 3.8 ± 3.0 years. NPS were comparably associated with future AD in men and women with MCI. Regarding CU participants, the following significant sex by NPS interactions were noted: female sex moderated the risk conferred by moderate/severe apathy (HR = 7.36, 3.25-16.64) by 74%, mitigated the risk conferred by moderate/severe depression (HR = 3.61, 2.08-6.28) by 52%, and augmented the risks conferred by mild depression (HR = 1.00, 0.60-1.68) and agitation (HR = 0.81, 0.40-1.64) by 83% and 243%, respectively. Apathy, depression and agitation were differentially associated with incident AD in CU men and women. No individual NPS was associated with different risks of future AD in men versus women with MCI.

Identifiants

pubmed: 36572715
doi: 10.1007/s00415-022-11541-w
pii: 10.1007/s00415-022-11541-w
pmc: PMC10025238
mid: NIHMS1866856
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2069-2083

Subventions

Organisme : NIA NIH HHS
ID : P20 AG068053
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066515
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062421
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066519
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072973
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062422
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066462
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066530
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066509
Pays : United States
Organisme : NIA NIH HHS
ID : P20 AG068077
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066546
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072972
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072979
Pays : United States
Organisme : NIA NIH HHS
ID : P20 AG068082
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072975
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066444
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066507
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072946
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066518
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066511
Pays : United States
Organisme : NIA NIH HHS
ID : U24 AG072122
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066512
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG016976
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066508
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072978
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062429
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072977
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062677
Pays : United States
Organisme : NIA NIH HHS
ID : P20 AG068024
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072958
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062715
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066506
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066468
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072976
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072947
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072931
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066514
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072959
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Brain Sci. 2022 Oct 08;12(10):
pubmed: 36291299
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
NCHS Data Brief. 2020 Sep;(379):1-8
pubmed: 33054920
J Alzheimers Dis. 2022;89(2):709-719
pubmed: 35912747
Arch Neurol. 1999 Mar;56(3):303-8
pubmed: 10190820
Am J Geriatr Psychiatry. 2013 Feb;21(2):119-28
pubmed: 23343485
Sci Rep. 2021 Mar 19;11(1):6448
pubmed: 33742011
Dement Geriatr Cogn Disord. 2020;49(2):146-155
pubmed: 32289790
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
Am J Psychiatry. 2014 May;171(5):572-81
pubmed: 24700290
Int Psychogeriatr. 2018 Feb;30(2):177-184
pubmed: 28416030
Int J Geriatr Psychiatry. 2021 Sep;36(9):1362-1369
pubmed: 33724517
J Intern Med. 2004 Sep;256(3):240-6
pubmed: 15324367
J Neurol Neurosurg Psychiatry. 2020 Mar;91(3):236-244
pubmed: 31879285
Alzheimer Dis Assoc Disord. 2016 Apr-Jun;30(2):134-9
pubmed: 26485498
Cogn Emot. 2018 Nov;32(7):1391-1400
pubmed: 28608767
Clin Psychopharmacol Neurosci. 2021 May 31;19(2):181-189
pubmed: 33888648
J Alzheimers Dis. 2020;73(1):125-133
pubmed: 31744004
Aging Clin Exp Res. 2023 Jan;35(1):41-51
pubmed: 36322329
Front Pharmacol. 2019 Sep 27;10:1109
pubmed: 31611794
Arch Gen Psychiatry. 2010 May;67(5):489-96
pubmed: 20439830
Neurology. 1998 Dec;51(6):1546-54
pubmed: 9855500
JAMA. 2002 Sep 25;288(12):1475-83
pubmed: 12243634
Neurology. 1993 Feb;43(2):250-60
pubmed: 8094895
J Affect Disord. 2016 Jan 15;190:264-271
pubmed: 26540080
Medicina (Kaunas). 2022 Nov 03;58(11):
pubmed: 36363543
Alzheimer Dis Assoc Disord. 2007 Jul-Sep;21(3):249-58
pubmed: 17804958
Alzheimers Res Ther. 2022 Apr 4;14(1):48
pubmed: 35379344
Am J Psychiatry. 2000 May;157(5):708-14
pubmed: 10784462
J Int Neuropsychol Soc. 2022 Oct 21;:1-9
pubmed: 36268843
Neurology. 1994 Dec;44(12):2308-14
pubmed: 7991117
Alzheimers Res Ther. 2020 Mar 31;12(1):35
pubmed: 32234066
Am J Alzheimers Dis Other Demen. 2018 Nov;33(7):450-457
pubmed: 29969907
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):91-101
pubmed: 19474567
Neurology. 2005 Dec 27;65(12):1863-72
pubmed: 16237129
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):210-6
pubmed: 17132964
Front Psychiatry. 2021 Dec 20;12:792168
pubmed: 34987434
Dement Geriatr Cogn Disord. 2007;24(4):253-9
pubmed: 17700021
J Am Med Dir Assoc. 2019 Aug;20(8):1054.e1-1054.e9
pubmed: 30926409
Medicina (Kaunas). 2022 Dec 09;58(12):
pubmed: 36557016
Alzheimers Res Ther. 2021 May 5;13(1):95
pubmed: 33952308
J Alzheimers Dis. 2010;20(1):175-83
pubmed: 20164594
Arch Gen Psychiatry. 2008 Oct;65(10):1193-8
pubmed: 18838636

Auteurs

Ioannis Liampas (I)

Department of Neurology, Faculty of Medicine, School of Medicine, University Hospital of Larissa, University of Thessaly, Mezourlo Hill, 41100, Larissa, Greece. iliampas@uth.gr.

Vasileios Siokas (V)

Department of Neurology, Faculty of Medicine, School of Medicine, University Hospital of Larissa, University of Thessaly, Mezourlo Hill, 41100, Larissa, Greece.

Constantine G Lyketsos (CG)

Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.

Efthimios Dardiotis (E)

Department of Neurology, Faculty of Medicine, School of Medicine, University Hospital of Larissa, University of Thessaly, Mezourlo Hill, 41100, Larissa, Greece.
Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH